The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
Open accessAbstract
Metastatic disease is the major cause of cancer deaths, and recurrent tumors at distant organs are a critical issue. However, how metastatic tumor cells become dormant and how and why tumors recur in target organs are not well understood. In this study, we demonstrate that BMP7 (bone morphogenetic protein 7) secreted from bone stromal cells induces senescence in prostate cancer stem-like cells (CSCs) by activating p38 mitogen-activated protein kinase and increasing expression of the cell cycle inhibitor, p21, and the metastasis suppressor gene, NDRG1 (N-myc downstream-regulated gene 1). This effect of BMP7 depended on BMPR2 (BMP receptor 2), and BMPR2 expression inversely correlated with recurrence and bone metastasis in prostate cancer patients. Importantly, this BMP7-induced senescence in CSCs was reversible upon withdrawal of BMP7. Furthermore, treatment of mice with BMP7 significantly suppressed the growth of CSCs in bone, whereas the withdrawal of BMP7 restarted growth of these cells. These results suggest that the BMP7–BMPR2–p38–NDRG1 axis plays a critical role in dormancy and recurrence of prostate CSCs in bone and suggest a potential therapeutic utility of BMP7 for recurrent metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Metastasis to bone: causes, consequences and therapeutic opportunities
Mundy, G. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc867 · Cited by 2,777
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
Signal integration by JNK and p38 MAPK pathways in cancer development
Wagner, E. F., & Nebreda, Á. R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2694 · Cited by 2,586
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Chen, D., Zhao, M., & Mundy, G. R. (2004) · Growth Factors · doi:10.1080/08977190412331279890 · Cited by 1,915
Models, mechanisms and clinical evidence for cancer dormancy
Aguirre-Ghiso, J. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2256 · Cited by 1,677
Reversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457
Zeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346
A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye.
Dudley, A. T., Lyons, K. M., & Robertson, E. J. (1995) · Genes & Development · doi:10.1101/gad.9.22.2795 · Cited by 1,131
Luo, G., Hofmann, C., Bronckers, A. L., Sohocki, M., Bradley, A., & Karsenty, G. (1995) · Genes & Development · doi:10.1101/gad.9.22.2808 · Cited by 1,021
Bone morphogenetic protein receptors and signal transduction
Miyazono, K., Kamiya, Y., & Morikawa, M. (2010) · Journal of Biochemistry · doi:10.1093/jb/mvp148 · Cited by 999
Friedlaender, G. E., Perry, C. R., Cole, J. D., Cook, S. D., Cierny, G., Muschler, G. F., Zych, G. A., Calhoun, J. H., LaForte, A. J., & Yin, S. (2001) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200100002-00010 · Cited by 957
Celeste, A. J., Iannazzi, J. A., Taylor, R. C., Hewick, R. M., Rosen, V, Wang, E. A., & Wozney, J. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9843 · Cited by 826
Ansieau, S., Bastid, J., Doreau, A., Morel, A.-P., Bouchet, B. P., Thomas, C., Fauvet, F., Puisieux, I., Doglioni, C., Piccinin, S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.005 · Cited by 715
The Increasing Complexity of the Cancer Stem Cell Paradigm
Rosen, J. M., & Jordan, C. T. (2009) · Science · doi:10.1126/science.1171837 · Cited by 698
Pamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate Cancer
Smith, M. R., McGovern, F. J., Zietman, A. L., Fallon, M. A., Hayden, D. L., Schoenfeld, D. A., Kantoff, P. W., & Finkelstein, J. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010845 · Cited by 696
Hoshino, R., Chatani, Y., Yamori, T., Tsuruo, T., Oka, H., Yoshida, O., Shimada, Y., Ari-i, S., Wada, H., Fujimoto, J., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202367 · Cited by 691
Sampath, T. K., Maliakal, J. C., Hauschka, P. V., Jones, W. K., Sasak, H., Tucker, R. F., White, K. H., Coughlin, J. E., Tucker, M. M., & Pang, R. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88709-4 · Cited by 678
Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
Zhang, X. H.-F., Wang, Q., Gerald, W., Hudis, C. A., Norton, L., Smid, M., Foekens, J. A., & Massagué, J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.017 · Cited by 663
OP-1 cDNA encodes an osteogenic protein in the TGF-beta family.
Ozkaynak, E., Rueger, D. C., Drier, E. A., Corbett, C., Ridge, R. J., Sampath, T. K., & Oppermann, H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07376.x · Cited by 554
Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases
Guise, T. A., Mohammad, K. S., Clines, G., Stebbins, E. G., Wong, D. H., Higgins, L. S., Vessella, R., Corey, E., Padalecki, S., Suva, L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1007 · Cited by 539
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538
Gene expression profiling predicts clinical outcome of prostate cancer
Glinsky, G. V., Glinskii, A. B., Stephenson, A. J., Hoffman, R. M., & Gerald, W. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20032 · Cited by 479
ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK)
Aguirre-Ghiso, J. A., Estrada, Y., Liu, D., & Ossowski, L. (2004) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2003.12.012 · Cited by 464
Aguirre-Ghiso, J. A., Liu, D., Mignatti, A., Kovalski, K., & Ossowski, L. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.4.863 · Cited by 446
Single-vector inducible lentiviral RNAi system for oncology target validation
Wiederschain, D., Susan, W., Chen, L., Loo, A., Yang, G., Huang, A., Chen, Y., Caponigro, G., Yao, Y.-M., Lengauer, C., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.3.7701 · Cited by 441
Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin
McAllister, S. S., Gifford, A. M., Greiner, A. L., Kelleher, S. P., Saelzler, M. P., Ince, T. A., Reinhardt, F., Harris, L. N., Hylander, B. L., Repasky, E. A., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.045 · Cited by 431
Bone morphogenetic proteins in the nervous system
Mehler, M. F., Mabie, P. C., Zhang, D., & Kessler, J. A. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01046-6 · Cited by 410
Bulavin, D. V., Phillips, C., Nannenga, B., Timofeev, O., Donehower, L. A., Anderson, C. W., Appella, E., & Fornace, A. J. (2004) · Nature Genetics · doi:10.1038/ng1317 · Cited by 409
Dormancy of Mammary Carcinoma After Mastectomy
Karrison, T. G., Ferguson, D. J., & Meier, P. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.1.80 · Cited by 407
Smith, M. R., Lee, W. C., Brandman, J., Wang, Q., Botteman, M., & Pashos, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.6908 · Cited by 366
Bone Morphogenetic Proteins in Vascular Calcification
Hruska, K. A., Mathew, S., & Saab, G. (2005) · Circulation Research · doi:10.1161/01.res.00000175571.53833.6c · Cited by 360
ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).
Aguirre‐Ghiso, J. A., Estrada, Y. D., Liu, D., & Ossowski, L. (2003) · PubMed · Cited by 348
Metastasis: a therapeutic target for cancer
Steeg, P. S., & Theodorescu, D. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1066 · Cited by 332
PRAK Is Essential for ras-Induced Senescence and Tumor Suppression
Sun, P., Yoshizuka, N., New, L., Moser, B. A., Li, Y., Liao, R., Xie, C., Chen, J., Deng, Q., Yamout, M., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.050 · Cited by 321
Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer.
Guan, R. J., Ford, H. L., Fu, Y., Li, Y., Shaw, L. M., & Pardee, A. B. (2000) · PubMed · Cited by 311
The Drg-1 gene suppresses tumor metastasis in prostate cancer.
Bandyopadhyay, S., Pai, S. K., Gross, S. C., Hirota, S., Hosobe, S., Miura, K., Saito, K., Commes, T., Hayashi, S., Watabe, M., et al. (2003) · PubMed · Cited by 308
Self-citationp38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation
Ventura, J. J., Tenbaum, S., Perdiguero, E., Huth, M., Guerra, C., Barbacid, M., Pasparakis, M., & Nebreda, A. R. (2007) · Nature Genetics · doi:10.1038/ng2037 · Cited by 304
Zeb1 links epithelial-mesenchymal transition and cellular senescence
Liu, Y., El-Naggar, S., Darling, D. S., Higashi, Y., & Dean, D. C. (2008) · Development · doi:10.1242/dev.007047 · Cited by 303
p38 MAP Kinase's Emerging Role as a Tumor Suppressor
(2004) · Advances in Cancer Research · doi:10.1016/s0065-230x(04)92005-2 · Cited by 290
The pathways to tumor suppression via route p38
Han, J., & Sun, P. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.06.007 · Cited by 267
van Belzen, N., Dinjens, W. N. M., Diesveld, M. P., Groen, N. A., van der Made, A. C., Nozawa, Y., Vlietstra, R., Trapman, J., & Bosman, F. T. (1997) · PubMed · Cited by 258
Reversal of Senescence in Mouse Fibroblasts through Lentiviral Suppression of p53
Dirac, A. M. G., & Bernards, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300023200 · Cited by 255
Ellen, T. P., Ke, Q., Zhang, P., & Costa, M. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm200 · Cited by 220
Dasari, A., Bartholomew, J. N., Volonte, D., & Galbiati, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1236 · Cited by 215
Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer
Buijs, J. T., Henriquez, N. V., van Overveld, P. G. M., van der Horst, G., Que, I., Schwaninger, R., Rentsch, C., ten Dijke, P., Cleton-Jansen, A.-M., Driouch, K., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2490 · Cited by 204
Buijs, J. T., Rentsch, C. A., van der Horst, G., van Overveld, P. G. M., Wetterwald, A., Schwaninger, R., Henriquez, N. V., ten Dijke, P., Borovecki, F., Markwalder, R., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070168 · Cited by 200
Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression
Bandyopadhyay, S., Pai, S. K., Hirota, S., Hosobe, S., Takano, Y., Saito, K., Piquemal, D., Commes, T., Watabe, M., Gross, S. C., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207734 · Cited by 194
Self-citationAguirre-Ghiso, J. A., Ossowski, L., & Rosenbaum, S. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0113 · Cited by 173
The Bone Morphogenetic Protein Pathway Is Inactivated in the Majority of Sporadic Colorectal Cancers
Kodach, L. L., Wiercinska, E., de Miranda, N. F. C. C., Bleuming, S. A., Musler, A. R., Peppelenbosch, M. P., Dekker, E., van den Brink, G. R., van Noesel, C. J. M., Morreau, H., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.059 · Cited by 168
Maruyama, Y., Ono, M., Kawahara, A., Yokoyama, T., Basaki, Y., Kage, M., Aoyagi, S., Kinoshita, H., & Kuwano, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0183 · Cited by 160
Chapter 11 Cell Cycle Analysis
Mitchison, J. M., & Carter, B. L. A. (1975) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)60324-6 · Cited by 158
The M‐type receptor PLA2R regulates senescence through the p53 pathway
Augert, A., Payré, C., de Launoit, Y., Gil, J., Lambeau, G. J., & Bernard, D. (2009) · EMBO Reports · doi:10.1038/embor.2008.255 · Cited by 153
Kitaura, H., Shinshi, M., Uchikoshi, Y., Ono, T., Tsurimoto, T., Yoshikawa, H., Iguchi‐Ariga, S. M. M., & Ariga, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10477 · Cited by 137
The p38 Kinases MKK4 and MKK6 Suppress Metastatic Colonization in Human Ovarian Carcinoma
Hickson, J. A., Huo, D., Griend, D. J. V., Lin, A., Rinker-Schaeffer, C. W., & Yamada, S. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3676 · Cited by 132
Integrin α5β1 Promotes Survival of Growth-Arrested Breast Cancer Cells
Korah, R. M., Boots, M., & Wieder, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3853 · Cited by 131
Tront, J. S., Hoffman‐Liebermann, B., & Liebermann, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2013 · Cited by 120
Bandyopadhyay, S., Wang, Y., Zhan, R., Pai, S. K., Watabe, M., Iiizumi, M., Furuta, E., Mohinta, S., Liu, W., Hirota, S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0943 · Cited by 114
Self-citationThe clinical significance of circulating tumor cells
Pantel, K., & Alix‐Panabières, C. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0737 · Cited by 101
Li, J., & Kretzner, L. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1024918328162 · Cited by 89
Kodach, L. L., Bleuming, S. A., Musler, A. R., Peppelenbosch, M. P., Hommes, D. W., van den Brink, G. R., van Noesel, C. J. M., Offerhaus, G. J. A., & Hardwick, J. C. H. (2007) · Cancer · doi:10.1002/cncr.23160 · Cited by 83
Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1)
Chubinskaya, S., Kumar, B., Merrihew, C., Heretis, K., Rueger, D. C., & Kuettner, K. E. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00158-8 · Cited by 79
Morrissey, C. M., Brown, L. G., Pitts, T. E. M., Vessella, R. L., & Corey, E. (2010) · Neoplasia · doi:10.1593/neo.91836 · Cited by 74
Ando, T., Ishiguro, H., Kimura, M., Mitsui, A., Kurehara, H., Sugito, N., Tomoda, K., Mori, R., Takashima, N., Ogawa, R., et al. (2006) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2006.00618.x · Cited by 67
Ye, L., Lewis-Russell, J. M., Kynaston, H., & Jiang, W. G. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.05.003 · Cited by 55
Inflammation Joins the “Niche”
Peinado, H., Rafii, S., & Lyden, D. C. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.012 · Cited by 47
Telomerase activity in disseminated prostate cancer cells
Pfitzenmaier, J., Ellis, W. J., Arfman, E. W., Hawley, S. J., MCLAUGHLIN, P. O., Lange, P. H., & Vessella, R. L. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06194.x · Cited by 42
Cited by
Emerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067
Molecular principles of metastasis: a hallmark of cancer revisited
Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A., & Fares, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0134-x · Cited by 2,379
Metastatic colonization by circulating tumour cells
Massagué, J., & Obenauf, A. C. (2016) · Nature · doi:10.1038/nature17038 · Cited by 2,062
Pre-metastatic niches: organ-specific homes for metastases
Peinado, H., Zhang, H., Matei, I. R., Costa-Silva, B., Hoshino, A., Rodrigues, G., Psaila, B., Kaplan, R. N., Bromberg, J. F., Kang, Y., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.6 · Cited by 1,889
Extracellular vesicles in cancer — implications for future improvements in cancer care
Xu, R., Rai, A., Chen, M., Suwakulsiri, W., Greening, D. W., & Simpson, R. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0036-9 · Cited by 1,445
Metadata
- Authors
- Kobayashi, A., Okuda, H., Xing, F., Pandey, P. R., Watabe, M., Hirota, S., Pai, S. K., Liu, W., Fukuda, K., Chambers, C., Wilber, A., & Watabe, K.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2011-11-28
- Volume
- 208
- Issue
- 13
- Pages
- 2641-2655
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2106738771
- Cited by
- 427
- References
- 72
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.